Aromasin
Product Images NDC 54868-5261

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Aromasin (NDC 54868-5261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of 25 mg Package Label (Aromasin 25 mg Package Label)

Image Of 25 mg Package Label (Aromasin 25 mg Package Label)
This is a label for Aromasin 25 mg tablets distributed by Physicians Total Care, Inc., Tulsa, OK. The label shows the product's NDC number 54868-5261-0, lot number, and an expiration date. It also includes a barcode and manufacturing information indicating Pharmaica Italy S.P.A., Ascoli Piceno, IT.*
FDA Label Image

Image Of Aromasin Chemical Structure (Aromasin Chemical Structure)

Image Of Aromasin Chemical Structure (Aromasin Chemical Structure)
Chemical structure diagram of the active ingredient in Aromasin, showing the steroidal backbone with multiple rings, hydroxyl groups, and ketone functionalities.*
FDA Label Image

Image Of Figure 1.disease Free Survival Graph (Figure 1.disease Free Survival)

Image Of Figure 1.disease Free Survival Graph (Figure 1.disease Free Survival)
A Kaplan-Meier survival curve chart illustrating the proportion of patients surviving over time in months, comparing the treatments Exemestane and Tamoxifen. The chart includes hazard ratio (HR), confidence interval (CI), and p-value statistics along with the number of events and patients in each treatment group.*
FDA Label Image

Image Of Figure 2 Graph (Figure 2)

Image Of Figure 2 Graph (Figure 2)
A survival probability curve comparing Aromasin (exemestane) with megestrol acetate over time in weeks. The graph uses a solid magenta line for Aromasin and a dashed black line for megestrol acetate, showing the probability decreasing as weeks progress.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.